BCa18: EAU Update on Bladder Cancer

BCa18: European Association of Urology (EAU) Update on Bladder Cancer is organized by European Association of Urology (EAU) and will be held during Jun 08 - 09, 2018 at International Congress Center Munich (ICM), Munich, Bavaria, Germany.

The EAU Update on Bladder Cancer (BCa18) will focus on bladder cancer management for a fully interactive meeting led by a wide expert panel of medical oncologists and onco-urologists.

Diagnosis and therapeutic management strategies for urothelial tumors have rapidly evolved in recent years. Currently, there are ongoing clinical studies in every stage of the disease, looking into potential breakthrough immunotherapy studies. Genito-urinary cancer specialists and healthcare professionals are required to update their knowledge with the latest research outcomes, developments in guideline recommendations and the impact of best practices on clinical work.

Testing assessment will be offered before and after the meeting to assess the participant’s knowledge, diagnostic and surgical skills. Interactive breakout sessions will examine dilemmas in diagnosis, while faculty-led case discussions will explore potential conflict issues in multidisciplinary team approaches, the impact of pathology results and follow-up strategies in recurrent, malignant disease.

BCa18 will help participants anticipate relevant and crucial developments that will inform clinical practice. Assess and enhance your bladder cancer management skills during this compact and comprehensive update.

Course Objectives:

• To understand the Molecular classification and Genomics approach in Bladder Cancer
• To evaluate and review the new approaches and therapies in Non-Muscle Invasive Bladder Cancer (NMIBC)
• Muscle invasive bladder cancer, where are we?
• To review the role of Immunotherapy
• To update the palliative management of muscle-invasive BCa
• To update on NMIBC treatment
• Follow up in bladder cancer

Additional details will be posted as soon as they are available.